We are pleased to announce the official launch of MenoBrain, a Marie Skłodowska-Curie Doctoral Network (DN) funded under Horizon Europe, as of 1 September 2025. MenoBrain brings together 11 beneficiary institutions and 7 partner organisations across 10 European countries, with one aim in common: filling critical research gaps on the menopausal transition and postmenopause, improving mental and brain health care for women while reducing health disparities and fostering equitable, innovative solutions for an ageing population. MenoBrain is now recruiting 15 Doctoral Candidates (DCs) to begin in February 2026, for a maximum period of three years. Using advanced methods like MRI, DTI, PET, EEG and host-microbiome modelling, the project will explore how hormonal changes during menopause and therapies impact cognitive health, gut-brain communication and ageing.
It will identify biomarkers for early cognitive dysfunction detection, improve therapies and promote personalised healthcare for menopausal women. An online kick-off meeting was held on 7 October, gathering the consortium members and associated partners to align on scientific strategy, governance and training plans. Alzheimer Europe (AE) is an associated partner in this project. AE project officer, Cindy Birck, represented the organisation at the meeting.
For more information about MenoBrain, please visit: https://www.uniklinikum-jena.de/menobrain/en/
All PhD positions are listed via EURAXESS: https://euraxess.ec.europa.eu/jobs/379260